the
Capitalor
Private Equity
Venture Capital
Mergers and Acquisitions
Investment Trends
Strategic Insights
InTandem Capital-backed Vivo Infusion snaps up Neurology Institute of San Antonio and Vista Infusions
Vivo Infusion is a provider of ambulatory infusion services.
10 January 2025
|
Aayush Sood
Following the transaction, Vivo will have 20 locations across Texas including infusion centers in Dallas, Houston, Longview, Tyler and San Antonio
Vivo was founded in 2003
Based in New York City, InTandem targets small to mid-sized companies in select healthcare services sector
Vivo Infusion, which is backed by InTandem Capital Partners, has acquired the Neurology Institute of San Antonio and Vista Infusions, a neurological center and provider of ambulatory infusion services based in Texas. No financial terms were disclosed.
Vivo Infusion is a provider of ambulatory infusion services.
Following the transaction, Vivo will have 20 locations across Texas including infusion centers in Dallas, Houston, Longview, Tyler and San Antonio.
Apply to Xartup Fellowship Program
Get ₹1.5 Crore Technical Funding
“We are thrilled to continue to build on the reputation of NISA and Vista Infusions and welcome them into the Vivo family,” said Steve Rodgers, CEO of Vivo Infusion in a statement. “NISA and Vista continue Vivo’s emphasis as an infusion provider of choice for neurological and autoimmune diseases.”
Fifth Third Securities served as financial advisor to NISA and Vista Infusions for this transaction.
Vivo was founded in 2003.
Based in New York City, InTandem targets small to mid-sized companies in select healthcare services sector.
Startup news delivered to your mail
Recommended for you
Constellation to acquire ECP-backed energy producer Calpine for $26.6bn
New Mountain Capital to acquire healthcare tech firm Machinify
Palm Beach Capital invests in architecture firm MBI Companies